Страна: Великобритания
Език: английски
Източник: MHRA (Medicines & Healthcare Products Regulatory Agency)
Teicoplanin
Sanofi
J01XA02
Teicoplanin
400mg
Powder and solvent for solution for injection
Oral; Intramuscular; Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010700; GTIN: 5015265300159
IS THIS LEAFLET HARD TO SEE OR READ? PHONE 0845372 7101 FOR HELP ▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Targocid is and what it is used for 2. What you need to know before you are given Targocid 3. How to use Targocid 4. Possible side effects 5. How to store Targocid 6. Contents of the pack and other information 1. WHAT TARGOCID IS AND WHAT IT IS USED FOR Targocid is an antibiotic. It contains a medicine called ‘teicoplanin’. It works by killing the bacteria that cause infections in your body. Targocid is used in adults and children (including newborn babies) to treat bacterial infections of: - the skin and underneath the skin - sometimes called ‘soft tissue’ - the bones and joints - the lung - the urinary tract - the heart - sometimes called ‘endocarditis’ - the abdominal wall - peritonitis - the blood, when caused by any of the conditions listed above Targocid can be used to treat some infections caused by ‘_Clostridium difficile_’ bacteria in the gut. For this, the solution is taken by mouth. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN TARGOCID DO NOT USE TARGOCID IF: • you are allergic to teicoplanin or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before you are given Targocid if: • you are allergic to an antibiotic called ‘vancomycin’ • you have had a flushing of your upper p Прочетете целия документ
OBJECT 1 TARGOCID 400MG Summary of Product Characteristics Updated 01-Feb-2018 | SANOFI This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. Name of the medicinal product Targocid 400mg powder for solution for injection/infusion or oral solution 2. Qualitative and quantitative composition Each vial contains 400 mg teicoplanin equivalent to not less than 400,000 IU. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for solution for injection/infusion or oral solution Powder for solution for injection/infusion or oral solution: spongy ivory coloured homogeneous mass 4. Clinical particulars 4.1 Therapeutic indications Targocid is indicated in adults and in children from birth for the parenteral treatment of the following infections (see sections 4.2, 4.4 and 5.1): • complicated skin and soft tissue infections, • bone and joint infections, • hospital acquired pneumonia, • community acquired pneumonia, • complicated urinary tract infections, • infective endocarditis, • peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD), • bacteraemia that occurs in association with any of the indications listed above. Targocid is also indicated as an alternative oral treatment for _Clostridium difficile_ infection-associated diarrhoea and colitis. Where appropriate, teicoplanin should be administered in combination with other antibacterial agents. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 Posology and method of administration Posology The dose and duration of treatment should be adjusted according to the underlying type and severity of infection and clinical response of the patient, and patient factors such as age and renal function. Measurement of serum concentrations Teicoplanin trough serum concentra Прочетете целия документ